The largest database of trusted experimental protocols

Spss for version 25

Manufactured by IBM
Sourced in United States

SPSS for version 25.0 is a statistical software package developed by IBM. It provides a comprehensive set of tools for data analysis, including data management, statistical modeling, and reporting. The software is widely used in various industries and academic settings to analyze and interpret complex data.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using spss for version 25

1

Tumor Progression Predictors Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous data are expressed as medians and interquartile ranges. Categoric variables are expressed as frequencies and proportions. Repeated measures ANOVA was used to compare biochemical indicators of liver function. Survival curves were estimated by using the Kaplan-Meier method. Cox proportional hazards regression analyses were performed to determine signi cant baseline clinical-biologic and nodule parameters for the prediction of local and overall tumor progression-free survival rates. All variables with P < 0.200 were included in the multivariate analysis; a stepwise Cox proportional hazards regression model was used to evaluate their value as independent predictors. In stepwise regression, P < 0.05 was considered to indicate a signi cant difference. SPSS for version 25.0 (IBM, Armonk, New York, USA) was used for statistical analysis.
+ Open protocol
+ Expand
2

Tumor Progression Predictors Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous data are expressed as medians and interquartile ranges. Categoric variables are expressed as frequencies and proportions. Repeated measures ANOVA was used to compare biochemical indicators of liver function. Survival curves were estimated by using the Kaplan-Meier method. Cox proportional hazards regression analyses were performed to determine signi cant baseline clinical-biologic and nodule parameters for the prediction of local and overall tumor progression-free survival rates. All variables with P < 0.200 were included in the multivariate analysis; a stepwise Cox proportional hazards regression model was used to evaluate their value as independent predictors. In stepwise regression, P < 0.05 was considered to indicate a signi cant difference. SPSS for version 25.0 (IBM, Armonk, New York, USA) was used for statistical analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!